How Some People Are Resistant To HIV?


Related Posts:

Campbell Biology

Source: Urry, Lisa A.. Campbell Biology (p. 130). Pearson Education. Kindle Edition.

How Some People Are Resistant To HIV? (Campbell Biology)

Proteins on a cell’s surface are important in the medical field. For example, a protein called CD4 on the surface of immune cells helps the human immunodeficiency virus (HIV) infect these cells, leading to acquired immune deficiency syndrome (AIDS). Despite multiple exposures to HIV, however, a small number of people do not develop AIDS and show no evidence of HIV-infected cells. Comparing their genes with the genes of infected individuals, researchers learned that resistant people have an unusual form of a gene that codes for an immune cell-surface protein called CCR5. Further work showed that although CD4 is the main HIV receptor, HIV must also bind to CCR5 as a “co-receptor” to infect most cells. An absence of CCR5 on the cells of resistant individuals, due to the gene alteration, prevents the virus from entering the cells. This information has been key to developing a treatment for HIV infection. Interfering with CD4 causes dangerous side effects because of its many important functions in cells. Discovery of the CCR5 co-receptor provided a safer target for development of drugs that mask this protein and block HIV entry. One such drug, maraviroc (brand name Selzentry), was approved for treatment of HIV in 2007 and is now being tested to determine whether this drug might also work to prevent HIV infection in uninfected, at-risk patients.

– What immune cells send signals to other types of immune cells, including killer cells, which then destroy the infectious particle?

– What is a protein on the surface of white blood cells that is involved in the immune system as it acts as a receptor for chemokines?


Urry, Lisa A.. Campbell Biology. Pearson Education. Kindle Edition.

Related Research

Research Article: The emergence and evolution of the research fronts in HIV/AIDS research

Date Published: May 25, 2017 Publisher: Public Library of Science Author(s): David Fajardo-Ortiz, Malaquias Lopez-Cervantes, Luis Duran, Michel Dumontier, Miguel Lara, Hector Ochoa, Victor M. Castano, Dimitrios Paraskevis. Abstract: In this paper, we have identified and analyzed the emergence, structure and dynamics of the paradigmatic research fronts that established the fundamentals of the biomedical … Continue reading

Research Article: A Landmark Paper in HIV Research?

Date Published: November 25, 2005 Publisher: Public Library of Science Author(s): unknown Abstract: None Partial Text: The clinical trial published in PLoS Medicine on whether male circumcision can prevent HIV (DOI: 10.1371/journal.pmed.0020298) is a “landmark paper” in HIV research. So said the first reviewer we sent this paper to. It is the first randomized trial … Continue reading

Research Article: Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate

Date Published: January 9, 2013 Publisher: Public Library of Science Author(s): Kristin M. Narayan, Nitish Agrawal, Sean X. Du, Janelle E. Muranaka, Katherine Bauer, Daniel P. Leaman, Pham Phung, Kay Limoli, Helen Chen, Rebecca I. Boenig, Terri Wrin, Michael B. Zwick, Robert G. Whalen, Welkin E. Johnson. Abstract: Development of a vaccine for HIV-1 requires … Continue reading

Research Article: HIV Treatment-as-Prevention Research at a Crossroads

Date Published: June 3, 2014 Publisher: Public Library of Science Author(s): Till Bärnighausen, Nir Eyal, Daniel Wikler Abstract: In light of changing WHO guidelines for HIV treatment, Till Barnighausen and colleagues consider how large-scale HIV treatment-as-prevention trials can be adapted so that they can remain viable. Please see later in the article for the Editors’ Summary … Continue reading